For many years, natural healers and many in the medical community have understood the power of cannabis in helping to treat chronic pain. Active compounds in cannabis, particularly cannabidiol, or CBD, have been shown anecdotally and in scientific studies to bring about pain relief in test subjects. While research is still needed to determine dosing accuracy and frequency, advances in our understanding of CBD oils derived from cannabis have been achieved. Of note is a recent study conducted by the Cornell University College of Veterinary Medicine, which investigated a hemp oil product made for dogs suffering from chronic pain conditions. In this article, we will discuss the study as well as the background on hemp oil in treating a number of health conditions.
What is Cannabidiol?
Before discussing the CBD oil study conducted by Cornell University, it can be beneficial to introduce cannabidiol, one of numerous active chemical compounds found in cannabis. In medical marijuana production and use, CBD and a similar compound called tetrahydrocannabinol, or THC, are the focus of research. These two compounds are classed as cannabinoids, of which there are hundreds of examples. THC is the chemical compound that produces feelings of euphoria. In other words, THC is psychoactive, producing the “high” that recreational marijuana users desire.
CBD, on other hand, is not a psychoactive cannabinoid. Medical patients who rely on cannabis for relief may not want the side effects that THC brings to the table; for those with chronic pain, the debilitating high can get in the way of function and daily activity. Cannabis strains with high percentages in CBD were developed to provide these patients the relief they need without the disordered thinking and euphoria that is associated with THC. CBD oil derived from these strains boasts little, if any, of the psychoactive THC compound. Some states that have not legalized medical marijuana use, sale, and possession still allow CBD oil to be sold in the state, provided that THC levels are non-existent in those oil products.
The Cornell University Study
In a partnership with ElleVet Sciences, the College of Veterinary Medicine at Cornell University conducted a research study centered on a hemp oil product manufactured by ElleVet. The goal of the study was to determine the effectiveness of ElleVet’s Mobility soft chews in controlling pain and soreness in dogs. The study took place over an eight-month period and was designed as a placebo-controlled and double blind investigation – the first of its kind in the veterinary sciences. In addition to investigating the pain relief potential of the product, another component of the study was to determine dosage scheduling and dosage rate. Investigating how the product was metabolized and its exact chemical effect was also part of the research study.
ElleVet’s Mobility soft chews contain CBD derived from hemp oil as well as two other compounds, chondroitin and glucosamine, known to provide improvements in joint mobility in animals and humans. In the study, over 80% of dogs who used the soft chews experienced substantial reductions in pain, resulting in improved mobility. This was especially true for dogs suffering from osteoarthritis, chronic joint pain, geriatric pain and discomfort, and the loss of mobility resulting from age. Geriatric dogs in the study showed the most dramatic improvements in functional mobility. Researchers involved in the study endorsed the product, describing it as a “game changer” for the veterinary medical community. Further studies need to be conducted, but the partnership between ElleVet and Cornell University is already lining up new investigations. First, the group will research the effectiveness of the Mobility soft chews on mitigating surgical and oncological pain in dogs. Next, ElleVet’s hemp oil product developed for cats will also be investigated in a similar study to the original dog-oriented one.
CBD Oil in Scientific Studies
Cannabinoids have been studied by health researchers for many years. CBD, the active cannabinoid credited with pain relief, has been the focus of nearly 25,000 published studies. CBD oil is credited with many health benefits borne out by exhaustive research. Among these health benefits are:
- Anti-anxiety properties
- Chronic pain relief
- Anti-inflammatory action
- Reduction in seizure frequency in epileptic patients
For the commercial cannabis cultivator, high-CBD strains represent a unique opportunity to bring science-backed health benefits to the medical marijuana community. Edibles and concentrates produced from these strains are proving popular with medical cannabis patients and have found acceptance even in states where a stigma on cannabis consumption is still in existence. Eliminating the psychoactive high from the equation has been a game-changer for many in the medical cannabis production industry, allowing their products to be sold in states that have not yet legislated medical marijuana use and possession. The future is bright for the medical cannabis community, thanks to groundbreaking studies like the Cornell University investigation in treating patients struggling with chronic pain.